The number and severity of CVEs published that impact products developed by Agilonhealth over time
Signals from CVEs in this vendor scope (3 CVEs).
3 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2026-5781HIGH An authorization vulnerability in MphRx's Minerva V3.6.0, specifically in the '/minerva/moUser/update' endpoint, could allow an authenticated user with user modification privileges | Apr 28, 2026 | 8.8 | 31 | NO | NO |
CVE-2026-5779HIGH An insecure direct object reference (IDOR) vulnerability in MphRx's Minerva V3.6.0, specifically in the '/minerva/user/updateUserProfile' endpoint. This allows an authenticated use | Apr 28, 2026 | 8.8 | 31 | NO | NO |
CVE-2026-5780HIGH An insecure direct object reference (IDOR) vulnerability in MphRx's Minerva V3.6.0, specifically in the endpoint '/minerva/moUser/show/'. If this vulnerability is successfully expl | Apr 28, 2026 | 8.1 | 27 | NO | NO |
Signals from CVEs in this vendor scope (3 CVEs).
An overview of all social media posts that mention a CVE ID that affects a product developed by Agilonhealth.
Media articles that mention a CVE ID that affects a product developed by Agilonhealth — matched by CVE ID, not by vendor name.